Optimus Drugs Private Limited, a active private limited company, was established on 02 December 2003 in Shaikpet, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239TG2003PTC042155. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹410.00 Cr and a paid-up capital of ₹35.14 Cr.
Formerly known as Surya Kiran Labs Private Limited. It upholds a compliant status. Employing 895 professional, Its leadership includes Srinivasareddy Desireddy (Director), Santosh Kumar Mahil (Additional Director), Sumit Mohan Nadgir (Additional Director). Past directors included Prabhat Kumar Kulshershta, Srinivasareddy Desireddy, Ashwin Savio Trinidad. It holds ₹188.61 Cr open charges and ₹167.44 Cr settled loans. Its latest AGM occurred on 31 January 2025, with the balance sheet filed on 31 March 2024. It is based at 7Th Floor, Maximus Towers, 2A,, Raheja Mindspace It Park, Hitec City,, Shaikpet, Telangana, 500081.
U24239TG2003PTC042155
042155
02 December 2003
₹410.00 Cr
₹35.14 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Optimus Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasareddy Desireddy | Director | 30 Mar 2006 | Current |
| Santosh Kumar Mahil | Additional Director | 26 Jun 2025 | Current |
| Sumit Mohan Nadgir | Additional Director | 01 Apr 2025 | Current |
| Durga Prasad Reddy Avula | Director | 22 Sep 2022 | Current |
| Uma Rao | Director | 09 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2012 | Past |
| Pramod Abcsdd | Managing Director | 22 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 20 Oct 2023 | Past |
| Pramod Abcsdd | Additional Director | 26 Jun 2025 | Past |
| Pramod Abcsdd | Additional Director | 23 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Optimus Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.98% increase. The company also saw a substantial fall in profitability, with a 109.56% decrease in profit. The company's net worth Soared by an impressive increase of 119.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Optimus Drugs had a promoter holding of 99.98% and a public holding of 0.02%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,886,100,000.00
₹1,674,415,552.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2022 | Axis Bank Limited | ₹3.61 Cr | Open |
| 10 May 2022 | Hdfc Bank Limited | ₹1.00 Cr | Open |
| 16 Sep 2017 | Hdfc Bank Limited | ₹55.00 Cr | Open |
| 15 Sep 2017 | Hdfc Bank Limited | ₹40.00 Cr | Open |
| 25 Jun 2015 | Others | ₹64.00 Cr | Open |
Explore comprehensive loan charge details -
Optimus Drugs has a workforce of 895 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Optimus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimus Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Santosh Kumar Mahil was appointed as a Additional Director was appointed as a Additional Director on 26 Jun 2025 & has been associated with this company since 6 months 21 days . was completed.
Sumit Mohan Nadgir was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 9 months 15 days . was recorded as a recent event.
Optimus Drugs Private Limited last Annual general meeting of members was held on 31 Jan 2025 as per latest MCA records. was recorded as a recent event.
Progress on Uma Rao was appointed as a Director was appointed as a Director on 09 May 2024 & has been associated with this company since 1 year 8 months . was documented.
Optimus Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity A charge with Others of Rs. 64.00 Cr registered on 25 Jun 2015 with Charge ID 10577123 was modified on 10 Nov 2023. was completed.
The CIN of Optimus Drugs Private Limited is U24239TG2003PTC042155.
Optimus Drugs Private Limited is headquartered at 7Th Floor, Maximus Towers, 2A,, Raheja Mindspace It Park, Hitec City,, Shaikpet, Telangana, 500081.
Optimus Drugs Private Limited was incorporated on 02 December 2003.
The current directors of Optimus Drugs Private Limited are
The primary industry of Optimus Drugs Private Limited is Manufacturing.
Optimus Drugs Private Limited is unlisted.
The authorized capital of Optimus Drugs Private Limited is ₹410.00 Cr, and the paid-up capital is ₹35.14 Cr.
The compliance status of Optimus Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX